Literature DB >> 10490832

Murine fibroblasts lacking p21 undergo senescence and are resistant to transformation by oncogenic Ras.

C Pantoja1, M Serrano.   

Abstract

The cell-cycle inhibitor p21 is upregulated during senescence and upon induction of senescence-like arrest by oncogenic Ras. We have used primary fibroblasts derived from p21-null mice to evaluate the role of p21 in these processes. We find that primary p21-/- cells enter senescence and have a lifespan similar to wild-type cells. Upon immortalization, most wild-type and p21-/- cultures acquire alterations in either p53 or p16INK4a, further indicating that p21-deficiency is not sufficient by itself to allow immortalization. Primary p21-/- cells, like wild-type cells, respond to oncogenic Ras by accumulating p53 and p16INK4a, and by decreasing their proliferation rate. In agreement with this, p21-/- cells are refractory to neoplasic transformation by oncogenic Ras when compared to p53-/- cells. We conclude that, in murine fibroblasts, p21 is not essential neither for senescence nor for preventing neoplasic transformation by oncogenic Ras.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10490832     DOI: 10.1038/sj.onc.1202880

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  64 in total

1.  Targeted disruption of the three Rb-related genes leads to loss of G(1) control and immortalization.

Authors:  J Sage; G J Mulligan; L D Attardi; A Miller; S Chen; B Williams; E Theodorou; T Jacks
Journal:  Genes Dev       Date:  2000-12-01       Impact factor: 11.361

2.  Ablation of the retinoblastoma gene family deregulates G(1) control causing immortalization and increased cell turnover under growth-restricting conditions.

Authors:  J H Dannenberg; A van Rossum; L Schuijff; H te Riele
Journal:  Genes Dev       Date:  2000-12-01       Impact factor: 11.361

3.  Regions and activities of simian virus 40 T antigen that cooperate with an activated ras oncogene in transforming primary rat embryo fibroblasts.

Authors:  Tina M Beachy; Sara L Cole; Jane F Cavender; Mary J Tevethia
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

4.  A senescence rescue screen identifies BCL6 as an inhibitor of anti-proliferative p19(ARF)-p53 signaling.

Authors:  Avi Shvarts; Thijn R Brummelkamp; Ferenc Scheeren; Eugene Koh; George Q Daley; Hergen Spits; René Bernards
Journal:  Genes Dev       Date:  2002-03-15       Impact factor: 11.361

5.  Role of p14(ARF) in replicative and induced senescence of human fibroblasts.

Authors:  W Wei; R M Hemmer; J M Sedivy
Journal:  Mol Cell Biol       Date:  2001-10       Impact factor: 4.272

6.  Multiple E2F-induced microRNAs prevent replicative stress in response to mitogenic signaling.

Authors:  María J Bueno; Marta Gómez de Cedrón; Usua Laresgoiti; José Fernández-Piqueras; Ana M Zubiaga; Marcos Malumbres
Journal:  Mol Cell Biol       Date:  2010-04-19       Impact factor: 4.272

7.  HdmX overexpression inhibits oncogene induced cellular senescence.

Authors:  Kelly R Miller; Kevin Kelley; Rebecca Tuttle; Steven J Berberich
Journal:  Cell Cycle       Date:  2010-08-23       Impact factor: 4.534

8.  Cellular senescence and organismal ageing in the absence of p21(CIP1/WAF1) in ku80(-/-) mice.

Authors:  Bo Zhao; Erica K Benson; Ruifang Qiao; Xing Wang; Sunchin Kim; James J Manfredi; Sam W Lee; Stuart A Aaronson
Journal:  EMBO Rep       Date:  2008-12-12       Impact factor: 8.807

9.  G1 checkpoint failure and increased tumor susceptibility in mice lacking the novel p53 target Ptprv.

Authors:  Gilles Doumont; Alain Martoriati; Chantal Beekman; Sven Bogaerts; Patrick J Mee; Fabrice Bureau; Emanuela Colombo; Myriam Alcalay; Eric Bellefroid; Francesco Marchesi; Eugenio Scanziani; Pier Giuseppe Pelicci; Jean-Christophe Marine
Journal:  EMBO J       Date:  2005-08-18       Impact factor: 11.598

10.  The isolation of an immortalized and tumorigenic cell line from p21WAF1 null mouse bladders.

Authors:  Terence W McGarvey; Trang B Nguyen; John E Tomaszewski; S Bruce Malkowicz
Journal:  In Vitro Cell Dev Biol Anim       Date:  2002 Jul-Aug       Impact factor: 2.416

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.